Subject: Lead Generation and Optimization - Wrksp

From: Jan Labanowski <[email-masked]>
Date: Mon, 26 Feb 1996 13:26:20 -0500

Lead Generation and Optimization

    March 21-22, 1996
    Sheraton New Orleans Hotel
    New Orleans, Louisana

Contact/Organizer: Mark Alexay, Straegic Research Institute
                   212-302-1800, x251

Theme:

"Exploiting Drug Discovery Resources for Maximum Yield"

Topics Include:

-- Combinatorial Chemistry            -- High-Throughput Screening
-- Natural Products Screening         -- 2D and 3D Chemical Databases
-- Measurement of Chemical Diversity  -- De Novo Drug Design
-- Peptidomimetic Design              -- 2D and 3D QSAR
-- Structure-based Design             -- Models of Oral Bioavailability
-- X-Ray Crystallography              -- Solid Phase Chemistry
-- Pharmacophore Mapping              -- Flexible Docking

Conference Chairman:
     Alan Katz, Ph.D.
     Research Fellow, Structural Biology
     Dept. of Computational Chemistry
     Wyeth-Ayerst Research

Conference Co-Chairman:
     Frank K. Brown, Ph.D.
     Section Head, Chemoinformatics
     Glaxo-Wellcome, Inc.

UPDATE on participation:

     Among your collegues attending the March 21-22, 1996 conference are
representatives from this growing list of companies and universities:

- Proctor and Gamble - Sandoz Research Institute - Searle
- Abbott Laboratories - XOMA Corporation - Astra Arcus - Xavier University
- Pfizer - American Cyanamid - Dupont Merck - SmithKline Beecham 
- Akzo Nobel - Eli Lilly & Co. - National Institute of Health
- Hoechst AG  - Ciba Geigy - Roche Biosciences - COR Therapeutics 
- SIBIA - Rhone Poulenc Rorer - Bristol Myers Squibb 
- Johnson & Johnson PRI - Hoechst Marion Roussel - Pharmacia Upjohn 
- Sagami Chemical - Guilford dPharmaceuticals - Ono Pharmaceuticals 
- Cubist, Inc. - Specs and Biospecs - Nexstar Pharmaceuticals 
- Cambridge Neuroscience